Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
染色质重塑受损预示着晚期胆道癌患者接受改良吉西他滨联合S-1和纳武利尤单抗治疗后生存期更长:一项II期T1219研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-1152
Chiang, Nai-Jung; Tan, Kien Thiam; Bai, Li-Yuan; Hsiao, Chin-Fu; Huang, Chung-Yu; Hung, Yi-Ping; Huang, Chien-Jui; Chen, San-Chi; Shan, Yan-Shen; Chao, Yee; Huang, Yi-Hsiang; Lee, I-Cheng; Lee, Pei-Chang; Su, Yung-Yeh; Chen, Shu-Jen; Yeh, Chun-Nan; Chen, Li-Tzong; Chen, Ming-Huang